| scholarly article | Q13442814 |
| P2093 | author name string | Stocker R | |
| Hazell LJ | |||
| P2860 | cites work | Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: nitrogen-chlorine derivatives of bacterial components in bactericidal action against Escherichia coli | Q24564090 |
| Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol | Q24564131 | ||
| Determination of fatty acids in the main lipoprotein classes by capillary gas chromatography: BF3/methanol transesterification of lyophilized samples instead of folch extraction gives higher yields | Q67906714 | ||
| On the action of hypochlorite on human serum albumin | Q68077521 | ||
| Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal | Q68857189 | ||
| Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography | Q68980840 | ||
| Single vertical spin density gradient ultracentrifugation | Q69553503 | ||
| Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor | Q69635952 | ||
| Peroxidation of phospholipids promoted by myeloperoxidase | Q69849607 | ||
| Copper ions and hydrogen peroxide form hypochlorite from NaCl thereby mimicking myeloperoxidase | Q70137938 | ||
| Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines | Q70375073 | ||
| Long-lived oxidants generated by human neutrophils: characterization and bioactivity | Q71084427 | ||
| Fine structure of human aortic intimal thickening and fatty streaks | Q72587977 | ||
| Measurement of protein using bicinchoninic acid | Q26778491 | ||
| Studies on the chlorinating activity of myeloperoxidase | Q28235493 | ||
| Reassessment of Ellman's reagent | Q28274979 | ||
| The complete cDNA and amino acid sequence of human apolipoprotein B-100 | Q28304252 | ||
| Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition | Q28625661 | ||
| Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages | Q28678300 | ||
| A receptor-mediated pathway for cholesterol homeostasis | Q29616158 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Antioxidant defenses and lipid peroxidation in human blood plasma | Q33688237 | ||
| Isolation and characterization of sulfhydryl and disulfide peptides of human apolipoprotein B-100. | Q33700536 | ||
| Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation | Q33850346 | ||
| Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite | Q34048534 | ||
| Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid | Q34236440 | ||
| Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells | Q34526444 | ||
| Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein | Q34613071 | ||
| Generation of nitrogen-chlorine oxidants by human phagocytes | Q34617174 | ||
| Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture | Q34620804 | ||
| Oxidative damage to fibronectin. I. The effects of the neutrophil myeloperoxidase system and HOCl | Q34777504 | ||
| Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages | Q35863970 | ||
| Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids | Q36263522 | ||
| Oxidation of methionine residues in proteins of activated human neutrophils | Q37508674 | ||
| The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis | Q37605132 | ||
| Role of oxidatively modified LDL in atherosclerosis | Q37978587 | ||
| Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins | Q40099596 | ||
| N-(2-Oxoacyl)amino Acids and Nitriles as Final Products of Dipeptide Chlorination Mediated by the Myeloperoxidase/H2O2/Cl- System | Q40197363 | ||
| The ultraviolet fluorescence of proteins in neutral solution | Q41773649 | ||
| Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. | Q41874485 | ||
| The antioxidant action of human extracellular fluids. Effect of human serum and its protein components on the inactivation of alpha 1-antiproteinase by hypochlorous acid and by hydrogen peroxide | Q42011048 | ||
| The oxidative modification of low-density lipoproteins by macrophages | Q42795258 | ||
| 5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein | Q42862580 | ||
| Brominating oxidants generated by human eosinophils | Q43746020 | ||
| Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation | Q43858088 | ||
| Modifications of low-density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate | Q44014273 | ||
| A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. | Q45945242 | ||
| Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification | Q46508007 | ||
| Fluorometric assay of proteins in the nanogram range | Q47965597 | ||
| Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. | Q53887257 | ||
| The chloroperoxidase-catalyzed oxidation of thiols and disulfides to sulfenyl chlorides. | Q54254114 | ||
| Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid | Q61824681 | ||
| The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein | Q67504070 | ||
| Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation | Q67822470 | ||
| Sulfhydryl-selective fluorescence labeling of lipoprotein(a) reveals evidence for one single disulfide linkage between apoproteins(a) and B-100 | Q67904697 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| macrophage | Q184204 | ||
| P304 | page(s) | 165-172 | |
| P577 | publication date | 1993-02-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages | |
| P478 | volume | 290 ( Pt 1) |
| Q37366288 | 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima |
| Q42679591 | A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages |
| Q33693133 | A role for reduced coenzyme Q in atherosclerosis? |
| Q43777189 | Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. |
| Q73762580 | Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein |
| Q36297106 | Alpha-tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids |
| Q41449076 | Apolipoprotein oxidation in the absence of lipid peroxidation enhances LDL uptake by macrophages |
| Q40637436 | Apoptotic pathways involved in U937 cells exposed to LDL oxidized by hypochlorous acid |
| Q37364334 | Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease |
| Q37172222 | Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites |
| Q73072515 | Beta-blockers inhibit the modification of low-density lipoproteins by sodium hypochlorite in vitro |
| Q41481967 | Biochemistry and pathology of radical-mediated protein oxidation |
| Q42338456 | Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health |
| Q43685736 | Carnosine, the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups |
| Q42028055 | Characterization of non-covalent oligomers of proteins treated with hypochlorous acid |
| Q59807449 | Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase |
| Q44020614 | Comparative time-courses of copper-ion-mediated protein and lipid oxidation in low-density lipoprotein |
| Q43989150 | Comparison of two methods for radioiodination on the oxidizability properties of low density lipoprotein |
| Q34397148 | Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system |
| Q46812978 | Copper- and magnesium protoporphyrin complexes inhibit oxidative modification of LDL induced by hemin, transition metal ions and tyrosyl radicals. |
| Q77161290 | Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis |
| Q35747306 | Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis |
| Q34758389 | Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl. |
| Q43964246 | Effect of acetaminophen on the myeloperoxidase-hydrogen peroxide-nitrite mediated oxidation of LDL. |
| Q28344995 | Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions |
| Q41565256 | Endogenous and exogenous antioxidants and the generation of antigenic epitopes in oxidatively-modified LDL. |
| Q28360674 | Enhancement of macrophage survival and DNA synthesis by oxidized-low-density-lipoprotein (LDL)-derived lipids and by aggregates of lightly oxidized LDL |
| Q38455185 | Enteric lactoferrin attenuates the development of high-fat and high-cholesterol diet-induced hypercholesterolemia and atherosclerosis in Microminipigs |
| Q44219160 | Homocysteine promotes the LDL oxidase activity of ceruloplasmin |
| Q43650867 | Human neutrophils employ the myeloperoxidase/hydrogen peroxide/chloride system to oxidatively damage apolipoprotein A-I. |
| Q35764845 | Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems |
| Q40945169 | Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages |
| Q73103541 | Hypochlorite modified LDL are a stronger agonist for platelets than copper oxidized LDL |
| Q41952132 | Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation |
| Q43559341 | Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase |
| Q42252354 | Hypochlorite-modified low-density lipoprotein induces the apoptotic machinery in Jurkat T-cell lines |
| Q74445963 | Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells |
| Q40379637 | Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARgamma mRNA expression and modulates SR-BI gene expression in murine macrophages |
| Q41289645 | Hypochlorous acid and its pharmacological antagonism: an update picture |
| Q37406247 | Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival |
| Q43897071 | Hypochlorous acid-modified low-density lipoprotein inactivates the lysosomal protease cathepsin B: protection by ascorbic and lipoic acids |
| Q71431257 | Hypocholesterolemic and immunostimulatory effects of orally applied Enterococcus faecium M-74 in man |
| Q35764605 | Immunological evidence for hypochlorite-modified proteins in human kidney |
| Q37665476 | Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100. |
| Q28350068 | Increased atherosclerosis in myeloperoxidase-deficient mice |
| Q37705110 | Inflammation-associated S100 proteins: new mechanisms that regulate function. |
| Q35098331 | Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium |
| Q41574079 | Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for coenzyme Q in atherogenesis? |
| Q33759336 | Inhibition of myeloperoxidase-mediated hypochlorous acid production by nitroxides |
| Q73923990 | Kinetics of tryptophan oxidation in plasma lipoproteins by myeloperoxidase-generated HOCl |
| Q43943413 | Low density lipoprotein of synovial fluid in inflammatory joint disease is mildly oxidized. |
| Q41615081 | Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis |
| Q37091275 | Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. |
| Q98726639 | MicroRNA sequences modulating inflammation and lipid accumulation in macrophage "foam" cells: Implications for atherosclerosis |
| Q36551322 | Modified low-density lipoproteins and high-density lipoproteins. From investigation tools to real in vivo players |
| Q34006317 | Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis |
| Q55426892 | Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives. |
| Q73378050 | Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis |
| Q44733343 | Myeloperoxidase gene variation and coronary flow reserve in young healthy men. |
| Q46834806 | Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue: a potential pathway for somatic mutagenesis by macrophages |
| Q64077636 | Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition |
| Q34236265 | Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions |
| Q34006268 | Myeloperoxidase-generated oxidants and atherosclerosis |
| Q33852491 | Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro |
| Q46279450 | Not All Inner Ears are the Same: Otolith Matrix Proteins in the Inner Ear of Sub-Adult Cichlid Fish, Oreochromis Mossambicus, Reveal Insights Into the Biomineralization Process |
| Q73110368 | Oxidation of heparin-treated low density lipoprotein by peroxidases |
| Q24528264 | Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation |
| Q37806960 | Oxidative mechanisms and atherothrombotic cardiovascular disease |
| Q73370736 | Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCL in vitro |
| Q33554184 | Oxidative risk for atherothrombotic cardiovascular disease |
| Q34658022 | Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress |
| Q77910747 | Oxysterols and atherosclerosis |
| Q40343992 | Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases |
| Q48300156 | Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA. |
| Q41528108 | Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor |
| Q34405070 | Plant-derived phenolics inhibit the accrual of structurally characterised protein and lipid oxidative modifications |
| Q44247254 | Plasma phospholipid transfer protein-mediated reactions are impaired by hypochlorite-modification of high density lipoprotein |
| Q42550801 | Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia |
| Q37353371 | Presence of hypochlorite-modified proteins in human atherosclerotic lesions |
| Q74450852 | Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite |
| Q27021668 | Protein Oxidation in Aging: Does It Play a Role in Aging Progression? |
| Q34119149 | Quantification and significance of protein oxidation in biological samples |
| Q28375883 | Reactions of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products in addition to 3-chlorotyrosine |
| Q42995934 | Reagent or myeloperoxidase-generated hypochlorite affects discrete regions in lipid-free and lipid-associated human apolipoprotein A-I. |
| Q64887718 | Receptors for oxidized low density lipoprotein. |
| Q37446110 | Redox signaling in cardiovascular health and disease. |
| Q46468624 | Reducing oxidized lipids to prevent cardiovascular disease |
| Q41819702 | Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid |
| Q54034451 | Relative reactivity of lysine and other peptide-bound amino acids to oxidation by hypochlorite. |
| Q41051532 | Review of progress in sterol oxidations: 1987-1995. |
| Q61978284 | Salicylate inhibits LDL oxidation initiated by superoxide/nitric oxide radicals |
| Q61978281 | Salicylate promotes myeloperoxidase-initiated LDL oxidation: antagonization by its metabolite gentisic acid |
| Q41937076 | Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins |
| Q40126438 | Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein |
| Q37809431 | Taurine in cardiovascular disease |
| Q24682551 | The aryl hydrocarbon receptor is activated by modified low-density lipoprotein |
| Q59033590 | The effect of reagents mimicking oxidative stress on fibrinogen function |
| Q37433102 | The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals. |
| Q41628567 | The interplay of nitric oxide and peroxynitrite with signal transduction pathways: implications for disease |
| Q41565280 | The mechanism of the hypochlorite-induced lipid peroxidation |
| Q44804722 | The protective effects of HDL and its constituents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL. |
| Q30240734 | The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture. |
| Q36386406 | Tripping up Trp: Modification of protein tryptophan residues by reactive oxygen species, modes of detection, and biological consequences |
| Q61978290 | Tyrosine: an inhibitor of LDL oxidation and endothelial cell cytotoxicity initiated by superoxide/nitric oxide radicals 1 |
| Q34787028 | Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation |
| Q73853371 | Urate attenuates oxidation of native low-density lipoprotein by hypochlorite and the subsequent lipoprotein-induced respiratory burst activities of polymorphonuclear leukocytes |
| Q36636155 | VPO1 mediates ApoE oxidation and impairs the clearance of plasma lipids |
| Q41998801 | Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein |
| Q41769762 | When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid |
| Q31924329 | p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL. |
Search more.